Urief Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Silodosin

Indications/Uses

Bladder outlet obstruction associated w/ BPH in patients ≥50 yr.

Click to view Urief detailed prescribing information

Dosage/Direction for Use

Adult 4 mg bd. Hepatic impairment Start treatment at 2 mg/dose.

Click to view Urief detailed prescribing information

Overdosage

View Urief overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Take after breakfast & evening meal.

Contraindications

Hypersensitivity.

Click to view Urief detailed prescribing information

Special Precautions

Reduce dose or discontinue use if decreased BP occurs. Orthostatic hypotension. Retrograde ejaculation. Intraoperative floppy iris syndrome. Concomitant use w/ PDE-5 inhibitors, α₁-blockers & other hypotensive drugs. May affect ability to drive & use machines. Hepatic & renal impairment. Male fertility. Elderly.

Click to view Urief detailed prescribing information

Use In Pregnancy & Lactation

Click to view Urief detailed prescribing information

Adverse Reactions

Abnormal ejaculation; thirst; increased triglycerides.

Click to view Urief detailed prescribing information

Drug Interactions

Blocked metabolism w/ potent CYP3A4 inhibitors. Diminished ability to regulate BP on standing w/ hypotensive agents. Elevated plasma conc w/ azole antifungals eg, itraconazole, ketoconazole. Enhanced hypotensive effect w/ PDE-5 inhibitors eg, sildenafil citrate, vardenafil HCl hydrate.

Click to view Urief detailed prescribing information

Storage

View Urief storage conditions for details to ensure optimal shelf-life.

Description

View Urief description for details of the chemical structure and excipients (inactive components).

Action

View Urief mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Drugs for Bladder & Prostate Disorders

ATC Classification

G04CA04 - silodosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

Urief FC tab 4 mg

Packing/Price

3 × 10's

Urief

silodosin

Manufacturer:

Eisai

Distributor:

DKSH